AMZN
Amazon.com, Inc.
AMZN has the edge over DKS overall, supported by stronger valuation and stronger fundamentals.
DKS
DICK'S Sporting Goods, Inc.
DKS's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DKS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Under pressure | |
| Healthy |
DKS's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over DKS in the historical PE scenario, which offers more potential upside but is not a forecast.
DKS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.3x | $84.34 | -42% |
| Forward | 12x | $146 | — |
| Fair | 14x | $124 | -15% |
| Current | 16x | $146 | — |
| Expensive | 18x | $162 | +11% |
Historical ranges are pointers, not guarantees.
DKS's PE is in its expensive range at 16x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
DKS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect DKS's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DKS on earnings, with more consistent year-over-year improvement.
DKS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $12.44 | +37% |
| Q3 2026 | $9.06 | -37% |
| Q2 2026 | $10.27 | -27% |
| Q1 2026 | $9.97 | -29% |
| Q4 2025 | $12.44 | -11% |
| Q3 2025 | $14.33 | +5.1% |
| Q2 2025 | $13.99 | +16% |
| Q1 2025 | $14.05 | +15% |
| Q4 2024 | $13.99 | +25% |
DKS's earnings per share have fallen from their peak: $9.06 over the past year, against $14.33 in mid-2025.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN's revenue has grown year over year every quarter since late 2020: $202B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DKS on profitability, with a higher operating margin.
DKS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.6B | +53% |
| Q2 2026 | $5.2B | +63% |
| Q1 2026 | $6.2B | +60% |
| Q4 2025 | $4.2B | +36% |
| Q3 2025 | $3.6B | +5% |
| Q2 2025 | $3.2B | +5.2% |
| Q1 2025 | $3.9B | +0.5% |
| Q4 2024 | $3.1B | +0.5% |
DKS has the edge over AMZN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | -4.5 points |
| Q2 2026 | 8.7% | -2.8 points |
| Q1 2026 | 3% | -7 points |
| Q4 2025 | 2.2% | -7.1 points |
| Q3 2025 | 12% | -1.1 points |
| Q2 2025 | 12% | +0.6 points |
| Q1 2025 | 9.9% | +0.3 points |
| Q4 2024 | 9.4% | +0.4 points |
DKS's operating margin was 7.9% last quarter, down 4.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DKS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $133M | -55% |
| Q2 2026 | -$84.2M | +$2.5M |
| Q1 2026 | $706.2M | +79% |
| Q4 2025 | -$515.6M | -$376.3M |
| Q3 2025 | $296.2M | +65% |
| Q2 2025 | -$86.7M | -217% |
| Q1 2025 | $394.5M | -33% |
| Q4 2024 | -$139.3M | -$49.6M |
DKS has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over DKS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DKS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -277K shares |
| 1 year | +11% | +9.1M shares |
| 3 years | +3.9% | +3.3M shares |
| 5 years | -18% | -19.1M shares |
| Available history | +4.1% | +3.5M shares |
DKS has 90M diluted shares, up 11% from a year ago, despite $185M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $141.2M |
| Q1 2026 | $43.5M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $303.7M |
| Q1 2025 | $92.8M |
| Q4 2024 | $6.7M |
DKS spent $185M buying back its own shares over the past year, down 54% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DKS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.6x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.0x | Very low |
DKS has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DKS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 24.3 | Neutral |
DKS's weekly RSI is 38 (neutral) and its Stochastic is 24 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DKS PE vs Consumer Cyclical Sector
| Metric | DKS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 71 | 47 | 24 pts above |
DKS has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DKS on trend strength, trading above more of its moving averages.
DKS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $141.1 | 3.3% above |
| 20 week MA | $166.3 | 12% below |
| 50 week MA | $194.2 | 25% below |
| 100 week MA | $202.5 | 28% below |
| 200 week MA | $184.0 | 21% below |
DKS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 21% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DKS on returns for 2026, with the stronger performance.
DKS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.2 | $55.6 | +15% |
| 2021 | $55.6 | $103.9 | +87% |
| 2022 | $103.9 | $111.1 | +6.9% |
| 2023 | $111.1 | $147.0 | +32% |
| 2024 | $147.0 | $234.1 | +59% |
| 2025 | $234.1 | $210.3 | -10% |
| 2026 YTD | $210.3 | $145.7 | -31% |
DKS is down 31% so far in 2026, after finishing higher in five of the previous six years.